SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-13-000039
Filing Date
2013-02-20
Accepted
2013-02-19 17:38:10
Documents
2
Effectiveness Date
2013-02-20

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1100
2 opxaw-form25.txt EX-99.25 107
  Complete submission text file 0001354457-13-000039.txt   3089
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-33004 | Film No.: 13624533
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850
Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144
NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE